Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more
Wednesday, September 20, 2017
Recipharm has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products.
read more
Wednesday, August 26, 2015
Recipharm AB has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma Ltd for the manufacturing of RedHill’s leading, late-stage patented drug candidate, RHB-105.
read more
The company earmarks new EUR 90 million loan facility for further acquisition of niche CDMOs, investment in existing facilities and building long term partnerships with major pharmaceuticals companies.
read more
Tuesday, November 10, 2015
Recipharm has signed an agreement with Daewoong, a leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year extension of its existing contract, through to 2025, for the manufacture and supply of ...
read more
Recipharm announced new product development contracts leveraging its Blow-Fill-Seal (BFS) technology.
read more
Tuesday, October 09, 2018
Recipharm has released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.
read more
Further to the announcement on 18th April 2016 that Recipharm would acquire the pharma division of Kemwell’s Indian operation, the Indian Foreign Investment Promotion Board has now granted approval for this transaction to take place.
read more
Wednesday, January 28, 2015
Recipharm, the leading contract development and manufacturing organisation (CDMO), is pleased to announce its readiness for serialisation and the successful completion of a complex serialisation project for China on behalf of one of its customers. A ...
read more
Recipharm has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery of Emla™ Patch to Japan.
read more
Tuesday, December 17, 2019
Recipharm, the CDMO, has partnered with biotechnology company Aptahem, for the formulation of Apta-1 drug candidate.
read more
Recipharm, has opened a GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina.
read more
Wednesday, March 03, 2021
Recipharm has announced its 2020 International Environmental Award will be presented to Dr. Amy Pruden, Professor of Civil and Environmental Engineering at Virginia Tech in Blacksburg, Virginia.
read more
Recipharm has announced that its 2017 International Environmental Award will be presented to Karen Kidd, Professor in Biology, and Geography & Earth Sciences.
read more
Recipharm AB has signed two separate agreements to acquire Kemwell’s pharmaceutical contract development and manufacturing (CDMO) businesses.
read more